|
|
||||||||
1 Institute for Experimental Medical Research, University of Oslo, Ullevaal Hospital, Oslo, Norway; and 2 Departments of Medicine (Cardiology) and Molecular Pharmacology and Biological Chemistry and The Feinberg Cardiovascular Research Institute, Northwestern University Medical School, Chicago, Illinois 60611
| |
ABSTRACT |
|---|
|
|
|---|
Excitation-contraction (E-C) coupling was
investigated in rat hearts 6 wk after induction of myocardial
infarction (MI) by ligation of the left coronary artery. Heart weight
was increased by 74% and left ventricular end-diastolic pressure was
23 ± 2 mmHg in MI compared with 8 ± 2 mmHg in sham-operated
controls (Sham, P < 0.001). Cell shortening was
measured in voltage-clamped myocytes at 36°C. In solutions where
Cs+ had been replaced by K+, the voltage
dependence of contraction was sigmoidal between
20 and +100 mV in
Sham and MI cells. Verapamil (20 µM) blocked L-type Ca2+
current and reduced contraction in Sham cells by ~50%
(P < 0.01) but did not decrease contraction
significantly in MI cells at test potentials above +10 mV.
Verapamil-insensitive contractions were blocked by Ni2+ (5 mM). Na+/Ca2+ exchange current was doubled in
MI compared with Sham cells at test potentials between
20 and +80 mV
(P < 0.05), whereas mRNA and protein expression
increased by 30-40%. Finally, voltage dependence of contraction
was bell shaped in Na+-free solutions, but contraction was
significantly increased in MI cells over a wider voltage range
(P < 0.05). The insensitivity to Ca2+
channel block in MI cells may result from an increased contribution of
the Na+/Ca+ exchanger to triggering of E-C
coupling. These results suggest significant changes in E-C coupling in
the hypertrophy and failure that develop in response to extensive MI.
calcium channels; contractility; heart failure; hypertrophy; excitation-contraction coupling; myocardial infarction
| |
INTRODUCTION |
|---|
|
|
|---|
THE DEVELOPMENT OF CONGESTIVE heart failure (CHF) is one of the most serious outcomes of myocardial infarction (MI). CHF is also the end stage of a variety of other conditions, such as hypertension, valvular disease, and cardiomyopathies almost invariably associated with cardiac hypertrophy. It is unclear whether hypertrophy and CHF are associated with reduced cell shortening. Most studies, some of which are based on quite heterogeneous human material, have demonstrated a decrease in the magnitude of contractions and intracellular Ca2+ transients as well as a slowing in time to peak and relaxation of the mechanical and Ca2+ signals (6, 11, 14, 15). However, these changes in mechanical function are most obvious at elevated Ca2+ concentrations and heart rates (11). Other in vitro studies of heart failure do not show reduced contractility, including one of myocardial strips from explanted human hearts (34) and another on isolated cells from rats with MI (1). The Ca2+ current (ICa) through L-type Ca2+ channels seems to be unchanged in failing human (5, 6) and pacing-induced hypertrophy and CHF in dog (31) myocytes. One might therefore speculate that the coupling between ICa and Ca2+ release from the sarcoplasmic reticulum (SR) is highly variable depending on the specific disease conditions and choice of experimental models. Indeed, a recent report suggests a reduced efficiency of the coupling between the sarcolemmal trigger and the Ca2+ release response of the SR during hypertrophy and CHF in a strain of rats with salt-sensitive hypertension (14).
Other mechanisms might also be involved in alterations in excitation-contraction (E-C) coupling in hypertrophy and CHF. It has been proposed that Na+/Ca2+ exchange, working in its reverse (Ca2+ influx) mode, can trigger Ca2+ release from the SR (4, 23, 27, 32). The sarcolemmal Na+/Ca2+ exchange protein and mRNA have been reported to be upregulated in CHF (35, 40). In line with this, enhanced Na+/Ca2+ exchange activity was observed in a genetic model of cardiomyopathy (17). However, in an MI model in which direct electrophysiological measurements were used, it was reported that Na+/Ca2+ exchange current (INaCaX) is decreased in CHF (47).
To examine these possible alterations in E-C coupling, we investigated changes in the contribution of ICa to E-C coupling in a well-controlled model of hypertrophy and CHF after MI in normal Wistar rats. The extent of the MI was such that acute cardiac insufficiency was avoided, but already after 1 wk there were signs of hypertrophy and failure (41) closely mimicking the disease state in humans. Furthermore, experimental conditions were chosen to ensure that normal temperature and transmembrane K+ gradient were maintained, since recent results have indicated that lower temperatures and substitution of Cs+ for K+ might have direct influences on E-C coupling (25, 42).
| |
METHODS |
|---|
|
|
|---|
Induction of MI. Methods for induction of MI and hypertrophy have been published elsewhere (41), as have the characteristics of the resulting cardiac disease (38). Extensive MI was induced by ligature of the left coronary artery in male Wistar rats weighing ~300 g under halothane anesthesia according to a protocol approved by the Norwegian National Committee for Animal Care and Use conforming to the Norwegian Animal Welfare Act and National Institutes of Health guidelines. Sham animals were treated identically, except no ligature was placed on the left coronary artery. Animals were kept for 6 wk before isolation of myocytes, during which time they developed a well-defined and organized scar area. The surviving myocardium showed no inflammatory reaction or collagen deposit (38). At this time the animals were again anesthetized with halothane, and left ventricular end-diastolic pressure (LVEDP) was measured by means of a 2-F micromanometer-tipped catheter (model SPR-407, Millar Instruments) inserted through the right carotid artery before the hearts were rapidly removed for further processing. Only MI animals with LVEDP >15 mmHg were included in the study. Compared with the gradual development of CHF in humans, 6 wk is a short period. However, the acute inflammatory reaction has subsided at this time and the clinical picture resembles the human condition quite closely, in that the hearts are hypertrophied and increased LVEDP is required to maintain cardiac output. Thus this experimental model produces reliable eccentric hypertrophy and volume overload of the left ventricle.
Measurements of ionic current and cell shortening. Cells were isolated using a Langendorff setup with retrograde perfusion of collagenase solution as described elsewhere (18, 41). The perfusion solution was based on a modified Joklik's medium (catalog no. 22300, Life Technologies). Only cells from the surviving part of the left ventricle were suspended in medium 199 (catalog no. M7528, Sigma Chemical), and >70% were rod shaped. Isolated cells were placed on laminated coverslips until use within 24 h of isolation. The coverslip was used as the floor of the experimental chamber on the stage of a Nikon Diaphot inverted microscope. The chamber (200 µl volume) was superfused at 36 ± 1°C at a rate of 2-3 ml/min. Myocyte contraction was measured with a video edge detector.
Patch-clamp experiments were performed using borosilicate glass pipettes (3-5 M
) connected to a holder with a sidearm port for
application of suction. We used the discontinuous (Axoclamp 2B
amplifier, switching rate 20 kHz) or the continuous whole cell voltage-clamp configuration (Axopatch 200B amplifier with series resistance compensation) with a 3-kHz low-pass filter. Data acquisition (5 kHz) and analysis were accomplished using pCLAMP6 software. All
voltage-clamp protocols included conditioning prepulses as indicated.
Prepulse trains were adjusted throughout each experiment to ensure the
maximal SR Ca2+ load that did not cause Ca2+
overload, as evidenced by the appearance of mechanical oscillations (aftercontractions) between the last prepulse and the test pulse. During this 500-ms period, holding potential
(Vh) was maintained to allow full recovery from
inactivation of L-type Ca2+ channels. Also, this period was
short enough to maintain the use-dependent block by verapamil
(unpublished data).
Four different kinds of experiments were performed. Recording
conditions and protocols were as follows: 1) To study the
voltage dependence of contraction, extracellular solution was a
modified Tyrode solution containing (in mM) 140 NaCl, 5.4 KCl, 0.5 MgCl2, 5 HEPES, 0.4 NaH2PO4, 11 glucose, and 1.8 CaCl2, and pH was adjusted to 7.4 with
NaOH. Intracellular solution contained (in mM) 120 potassium aspartate,
25 KCl, 0.5 MgCl2, 6 NaCl, 4 potassium ATP, 0.06 EGTA, and
20 HEPES, and pH was adjusted to 7.2 with KOH. After data were recorded
under control conditions, verapamil (20 µM) was added to the
superfusate directly from a 10 mM stock in distilled water, and
experimental protocols were repeated after 2 min of superfusion. Nickel
chloride (5 mM) was then added to the superfusate, and the protocols
were repeated. 2) For measurement of
ICa, the same external and internal solutions
described for the first type of experiment were used, with
Cs+ substituted for K+, 5 mM EGTA in the
internal solution, and ryanodine (2 µM) in the external solution. In
some experiments, Na+ current was blocked by substituting
Na+ with tetramethylammonium in the external solution or by
adding saxitoxin (3 µM, Vh
70 mV) or during
exposure to lidocaine (150 µM, Vh
40 mV).
All experimental conditions used for measuring ICa gave similar results, so data were pooled.
3) INaCaX was measured using a
modification of the methods described by Zhang et al. (47)
to increase the rate of reverse-mode exchange. The minor modifications
included a normal Tyrode solution containing 5 mM Ca2+ and
internal solution containing 25 mM Na+. In control
experiments, extracellular Ca2+ concentration was 0.5 mM
and intracellular Na+ was 0 mM to abolish reverse-mode
Na+/Ca2+ exchange. Internal and external
solutions were K+ free (Cs+ substitution).
Verapamil (5 µM) and ryanodine (5 µM) were present in the external
solution. Three prepulses to 0 mV were delivered for 50 ms at 1 Hz
before activation of the test pulse (1,000 ms). Vh was
40 mV, and test potential
(Vt) ranged up to +80 mV. Current measurements
were taken as the average of the last 300 ms of each Vt step. Nickel chloride (10 mM) was added to
the superfusate after completion of control recordings, and protocols
were repeated to obtain Ni2+-sensitive current.
4) Contractions in the absence of Na+ were
performed with the solutions described for the first type of
experiments (Cs+ free), but with tetramethylammonium
replacing Na+ in the external and internal solutions.
Northern blot analysis of mRNA for the Na+/Ca2+ exchanger. Poly(A)+ RNA was extracted from homogenized left ventricular tissue from MI and Sham rats. The infarct area was carefully removed, together with the right ventricle and the atria, leaving only viable tissue from the left ventricle. Oligo(dT)-conjugated paramagnetic beads were used to extract poly(A)+ RNA according to the manufacturer's instructions (Dynal, Oslo, Norway). The poly(A)+ RNA was size fractionated on a formaldehyde-agarose gel by use of 10 µg of poly(A)+ RNA per lane, transferred to a Biotrans nylon membrane (ICN Biomedicals), and hybridized at 42°C first for 3 days with a cDNA probe for the NCX1 (500 bp, kindly provided by Dr. K. D. Phillipson, University of California at Los Angeles) and after stripping for 1 day with a probe for glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1,300 bp, kindly provided by Dr. H. Prydz, University of Oslo, Norway). After hybridization, the Na+/Ca2+ exchanger and GAPDH membranes were washed four times at 35°C in 0.1× standard saline-sodium citrate (SSC)-0.1% SDS and 2× saline-sodium citrate-0.1% SDS at room temperature for 10 and 15 min and then washed twice for 15 min at 60°C. cDNA probes were randomly primed with [32P]dCTP and [32P]dATP, and stripping was carried out at 65°C for 1 h in a buffer containing 10 mM NaH2PO4 and 50% formamide at pH 6.5. The membranes were scanned and analyzed using PhosphorImager and ImageQuant software (both from Molecular Dynamics, Queensland, Australia). To estimate the Na+/Ca2+ exchanger mRNA tissue level, the Na+/Ca2+ exchanger transcript level-to-GAPDH transcript level ratios were calculated in each sample. For more precise quantification and to ensure linearity of transcript signal, a slot-blot analysis was carried out by applying 0.5, 1, and 2 µg of poly(A)+ RNA to a nylon membrane with use of a filtration manifold (Minifold II, Schleicher & Schuell, Dassel, Germany). The slot-blot membranes were subjected to the same procedure as the Northern membranes, and the Na+/Ca2+ exchanger transcript signal was normalized to the signal of an oligo(dT)18 probe (Eurogentec, Seraing, Belgium) for each sample.
Western blot analysis.
A Western blot analysis was performed on a crude membrane fraction
isolated from homogenates of left ventricles from Sham and MI hearts,
with care taken to exclude the infarct area (16, 30, 38). Protein concentration in the
membrane preparation was determined by a micro-bicinchoninic acid
protein assay (Pierce Chemical, Rockford, IL) with BSA as standard. The
proteins were size fractionated by SDS-PAGE on 8% polyacrylamide gels
as described by Laemmli (22) and electrophoretically
transferred to nitrocellulose membranes. After they were blocked with
10% nonfat dry milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T
buffer) for 1 h at room temperature, the membranes were incubated
for 1 h with a rabbit anti-Na+/Ca2+
exchanger polyclonal antibody (code
11-13, Swant, Bellinzona, Switzerland) diluted 1:1,000 in blocking solution for 1 h. After repeated washing in TBS-T buffer, the membranes were incubated with
anti-rabbit IgG conjugated to horseradish peroxidase (catalog no. NA
934, Amersham, Oakland, ON, Canada) as secondary antibody. Again,
repeated washing was carried out in TBS-T buffer. The immunoreactive bands were detected by the enhanced chemiluminescence method (RPN 2106, Amersham). The image was scanned and staining density was quantified
with ImageQuant.
Statistics. Values are means ± SE. Comparisons between means were made using Student's t-test with the Bonferroni correction for multiple comparisons when appropriate. A minimum of three animals was used in each group. Comparisons of averaged INaCaX were accomplished with multivariate ANOVA followed by Scheffé's test. Differences between sample means were considered significant when P < 0.05 unless specified otherwise.
| |
RESULTS |
|---|
|
|
|---|
Characteristics of the rat MI model.
Six weeks after ligation of the left coronary artery, heart weight was
74% higher in MI than in Sham rats (Table
1). Heart weight-to-body weight ratios
were also significantly increased, showing that a significant
hypertrophy had developed in the remaining viable part of the left
ventricle mainly localized to the septal region (Table 1). Left
ventricular systolic pressure was significantly lower and LVEDP
significantly higher in MI than in Sham rats. Together with an
increased lung weight (data not shown), this indicates that the animals
had developed CHF.
|
|
Voltage dependence of contraction in Sham and MI.
The characteristics of contraction and changes in E-C coupling after MI
were investigated under voltage-clamp conditions. Contractions were
elicited by voltage steps to Vt of
30 to +100 mV from a Vh of
40 mV, at which cell length
was stable and not different from the length at
80 mV throughout the
1-s period between the last prepulse and the test pulse. Maximum
shortening was greater at a Vt of +80 than 0 mV
by 47 ± 10 and 37 ± 11% in Sham and MI, respectively
(P < 0.05 in both groups). This is exemplified by the
two experiments shown in Fig. 1 (cf.
A and C with B and D), and
Table 2 gives mean data on fractional shortening at these two voltages.
There was no significant difference between Sham and MI cells at any
Vt. However, contractions were significantly slower in MI than in Sham, since time to peak contraction and time to
50% relaxation were increased at both Vt (Table
2).
|
30 mV in the Sham cells, reached a maximum value
at about +40 mV, and remained fairly constant up to +100 mV, giving a
sigmoidal dependence of contraction on Vt (Fig.
2A). The voltage dependence of contraction was nearly identical in MI cells under the same control conditions (Fig. 2B).
|
Verapamil sensitivity of contraction. The effects of verapamil and Ni2+ on voltage dependence of contraction in Sham and MI cells are illustrated by the two experiments in Fig. 1. Verapamil (20 µM) reduced the contraction at a Vt of 0 mV by 66% and at +80 mV by 48% in a Sham cell (Fig. 1, A and B). Subsequent addition of Ni2+ (4 mM) abolished the remaining verapamil-insensitive contraction at both voltages. Exposure of an MI cell to verapamil reduced contraction by 26% at 0 mV and by 19% at +80 mV (Fig. 1, C and D). Thus a high concentration of verapamil caused much less block of contraction at both Vt in the MI than in the Sham cell. Again, exposure to Ni2+ abolished the verapamil-insensitive component of contraction. Exposure to ryanodine (5 µM) blocked all verapamil-insensitive contraction in both cell types (n = 5; data not shown).
In both cell types, verapamil completely abolished the outward current at a Vt of 0 mV (Fig. 1, A and C), whereas some outward current was still detectable at +80 mV (Fig. 1, B and D). It is possible that this verapamil-sensitive current might be a Ca2+-activated K+ current (19). The effects of verapamil on the magnitude of contraction in Sham and MI cells over the full range of Vt are summarized in Fig. 2, A and B, respectively. Exposure to verapamil blocked contraction by ~50% at all Vt tested (P < 0.05 at all Vt above
30 mV) in Sham cells. In contrast,
exposure to verapamil had only modest effects on cell shortening at all
Vt in MI cells. The verapamil-sensitive component of cell shortening is compared in Fig. 2C for Sham
and MI myocytes. This drug produced a significant negative inotropic effect at nearly all Vt above
30 mV in Sham
cells. In contrast, the negative inotropic effect of verapamil in MI
cells was not significant, except between
20 and +10 mV. Verapamil
caused no significant change in shortening above and below this voltage range. These results demonstrate that cardiomyocytes isolated from the
viable part of the left ventricle of rats with MI show a significantly
diminished sensitivity to the effects of Ca2+ current
blockade compared with age-matched, sham-operated controls.
Effect of verapamil on ICa.
The efficacy of Ca2+ channel blockade by verapamil was
confirmed in each cell type in a separate series of experiments. Figure 3A shows the effects of
verapamil (20 µM) on Sham and MI cells. The
ICa density was nearly the same in the two cell
types under control conditions. These values from rats are almost three
times greater than in normal and failing human hearts (5,
31). Verapamil blocked inward current in both treatment
groups, as shown by the two inset current traces
(Vt = 0 mV) and by the summarized mean data
for all Vt. Thus it is likely that
ICa was blocked to the same extent in both cell
types, so that differential sensitivity to the Ca2+ channel
antagonist in the two cell types cannot underlie the resistance of MI
cells to the negative inotropic effects produced in Sham cells.
|
Relationship between ICa and contraction. Figure 3B summarizes the relationship between normalized current (from Fig. 3A) and normalized cell shortening under these conditions (data from Fig. 2, A and B). There was a close association between ICa and contraction amplitude over the voltage range of current activation (arrow) in the Sham cells until maximal current was reached (at 0 mV). Current declined with additional depolarization as the reversal potential for ICa was approached, but contraction continued to increase. Similar results were obtained in MI cells, demonstrating a close correlation between activation of ICa and contraction only up to the voltage range of peak current (~0 mV), above which current and contraction amplitudes become negatively correlated.
Measurements of INaCaX.
One possible contributor to activation of contraction in the absence of
ICa could be reverse-mode
Na+/Ca2+ exchange. We measured
INaCaX in Sham and MI cells to determine any
changes induced by MI. Under control conditions, successive depolarization ranging from
40 to +100 mV caused a progressively larger outward current, as seen in a Sham cell in Fig.
4A. Addition of
Ni2+ (10 mM) to the superfusate reduced the magnitude of
the outward currents at all Vt (Fig.
4B). The Ni2+-sensitive current, which is a
measure of INaCaX, is shown in Fig.
4C. When the identical protocol was applied to an MI cell (Fig. 4, D and E), INaCaX
was greater in the MI cell, as evidenced by the magnitude of the
Ni2+-sensitive current (Fig. 4F), whereas
Ni2+-insensitive currents were nearly the same. In control
experiments with 0 mM Na+ in the pipette,
Na+/Ca2+ exchange was inactive and
Ni2+ had no detectable effect on current in either cell
type.
|
20 mV (P < 0.05). These results
demonstrate an increase in the amount of outward
INaCaX, corresponding to Ca2+
influx, produced by Na+/Ca2+ exchange in MI
cells compared with Sham controls under conditions that favor
reverse-mode operation of the exchanger.
|
Quantification of the Na+/Ca2+ exchanger
mRNA signal and protein.
An important question is whether this increased outward
INaCaX represents an increase in the exchanger
protein or whether exchange kinetics are altered. Figure
6A shows a representative Northern blot. A strong signal was detected at 7 kb, and weaker signals
appeared at ~4.7 and 1.5 kb in accordance with previous reports
(9). When normalized against the GAPDH signal, the transcript signal from MI (n = 13) hearts exceeded the
Sham (n = 7) signal by 30-40% (P < 0.05). Figure 6A also shows a strong transcript signal
for the Na+/Ca2+ exchanger in the infarct area.
Figure 6B shows the summarized results from a separate
slot-blot analysis. Again, the signal from MI hearts (n = 13) exceeded that from the Sham hearts (n = 7, P < 0.05) by 37 ± 10%. The signal in the
infarct area was more than twice as strong as in Sham hearts.
|
|
Cell contractions in the absence of Na+.
To confirm that ICa can serve as an effective
trigger for E-C coupling in the absence of
Na+/Ca2+ exchange, we performed a separate
series of experiments in the absence of intracellular and extracellular
Na+. Figure 8 shows the
results of experiments performed in a Sham and MI cell in the absence
of Na+. The magnitude of net outward current in the
Na+-free solutions increased with depolarization in the
Sham cells; the magnitude of the outward current was dramatically
increased at all Vt in the MI cells. The nature
of this outward current was not examined further, but it could be a
chloride current; K+ currents are reduced in cardiac
hypertrophy and failure (7, 36), whereas
there seems to be sustained activation of chloride channels
(3, 10).
|
20 mV activated a phasic contraction that increased
as Vt was raised to 0 mV but then declined at
+30 mV in Sham cells. Similar results were obtained in the MI cell, in that cell shortening increased to a maximum at 0 mV and then declined at +30 mV.
The voltage dependence of contractions in the absence of
Na+ is summarized over a wide voltage range for Sham and MI
cells in Fig. 9A. Both
demonstrate the typical bell shape normally ascribed to the triggering
of contraction via Ca2+ influx through Ca2+
channels; the threshold for activation of contraction coincides with
activation of inward ICa at
30 mV, maximal
contraction and inward current were achieved at ~0 mV, and further
depolarization caused diminished contraction as the apparent reversal
potential for ICa was approached (at about +60
mV). Fractional contraction was not significantly different in MI and
Sham cells at 0 mV (5.0 ± 1 and 4.6 ± 1% in Sham and MI,
respectively). In contrast to Na+-containing solutions,
verapamil blocked the contraction at all Vt
(open symbols). Thus Sham and MI cell types demonstrate typical triggering of E-C coupling as a result of activation of L-type Ca2+ channels. However, a closer examination of the voltage
dependencies of contraction reveals subtle but important differences in
the coupling between ICa and contraction in the
MI cells; shortening is greater at
20, +30, and +40 mV in the MI than
in the Sham cells. The result is that nearly maximal activation occurs
over a broader range of Vt, from
20 to +30 mV,
in the MI compared with the narrow peak of activation in Sham cells
(
10 to +10 mV). These results demonstrate that the coupling between
ICa and SR Ca2+ release is not
suppressed in MI under our experimental conditions. On the contrary,
there was a greater contraction over a wider range of potentials
positive and negative to the peak at 0 mV, which might compensate for
the other alterations in shortening activation and relaxation kinetics.
|
| |
DISCUSSION |
|---|
|
|
|---|
We found that, in a model of experimentally induced MI with resulting hypertrophy and failure in rat hearts, isolated ventricular myocytes surviving the infarct show altered structure, physiological function, and pharmacological responses. Most importantly, the sensitivity of contraction to L-type Ca2+ channel blockade with verapamil was greatly reduced in MI compared with Sham cells, and the verapamil-insensitive contractions were blocked by Ni2+. Finally, there was an increased INaCaX, which might be responsible for a more prominent role of reverse-mode Na+/Ca2+ exchange in triggering contraction in MI, thus explaining the relative insensitivity of MI cells to the effects of verapamil.
Voltage dependence of E-C coupling after MI. E-C coupling has been studied extensively in isolated cardiac myocytes and has revealed that Ca2+-induced Ca2+ release is activated by Ca2+ influx through the L-type Ca2+ channel (2, 44). The resulting voltage dependence demonstrates a clear reliance of E-C coupling on ICa, giving a characteristic bell shape in which intracellular Ca2+ transients and contraction follow the voltage dependence of ICa. Thus it is somewhat surprising that contractions from Sham and MI cardiomyocytes demonstrate a sigmoidal dependence on Vt. The explanation for this result is likely to derive from recent reports suggesting that voltage-dependent activation of the reverse (Ca2+ influx) mode of Na+/Ca2+ exchange might contribute to triggering in a number of mammalian species including the rat (21, 23, 24, 26, 42). However, in normal cardiomyocytes the importance of the reverse-mode exchange for normal contraction has been questioned (39). The difference between these and many other reports demonstrating an exclusive reliance of activation on ICa is most likely the result of differences in experimental conditions; substitution of the primary physiological monovalent cation K+ with Cs+ is usually used to block K+ currents and thus isolate ICa. However, low temperatures and Cs+ replacement appear to suppress the apparent contribution of the exchanger to activation of contraction (25, 42, 43). The net result is that when the normal K+ gradient and physiological temperatures are used, the voltage dependence of contraction is indeed sigmoidal. The present study reveals that this is true for Sham and MI cells, suggesting that the exchanger contributes to triggering in normal myocytes and in myocytes surviving MI.
On the other hand, we also confirmed that there was clearly a direct reliance of contraction on ICa when there was no Na+ in internal or external solutions; indeed, all contraction was blocked by verapamil in Sham and MI cells under these conditions. This experiment serves as an important control for the effects of verapamil; if some minor fraction of ICa remained unblocked by verapamil, it is possible that even a small Ca2+ influx could be sufficient to activate significant contraction, which might subsequently be blocked completely by the addition of Ni2+. This was clearly not the case, as demonstrated by complete block of contractions by verapamil when ICa-activated contractions were isolated in Na+-free solutions. These experiments also revealed subtle differences between Sham and MI, in that there was a greater contraction across a wider voltage range in the MI than in the Sham cells, despite similar peak shortening. Under conditions where Na+/Ca2+ exchange is inoperative, we do not see the suppression of E-C coupling that was reported recently by Gomez et al. (14). The differences in results are likely to arise from differences in experimental conditions, including substitution of intracellular Cs+ vs. intracellular K+ and temperature. Furthermore, Gomez et al. used a salt-sensitive rat strain that develops hypertension and concentric ventricular hypertrophy and another inbred rat strain that develops signs of heart failure. In our rat model, echocardiography revealed significant myocardial failure at LVEDP >15 mmHg, as judged by the reduced velocity of shortening of the surviving posterior wall of the left ventricle (unpublished results).Altered sensitivity to verapamil in MI cells. The most striking observation in this study was that MI cells showed reduced sensitivity to block of contraction by verapamil compared with Sham cells, despite the demonstration that the same concentration of verapamil was highly effective in blocking ICa in both cell types.
Our observation that Sham cells showed a ~50% decrease in contraction with verapamil over most of the voltage range tested is consistent with a previous finding that nifedipine blocked contraction to the same extent in normal rat myocytes under similar experimental conditions (42). Other reports have demonstrated that, in addition to verapamil, ICa block with nifedipine and cadmium had similar effects to reduce contraction in cat and guinea pig myocytes (24, 43). In contrast, we found that verapamil caused only a modest but not statistically significant negative inotropic effect in MI cells, except in the voltage range where ICa was maximal, suggesting that E-C coupling in MI cells is less sensitive to ICa block by verapamil than in Sham cells. In all cases, the remaining contraction was also blocked by Ni2+, suggesting a common mechanism underlying contractions activated in the absence of functional L-type Ca2+ channels.Changes in INaCaX after MI. There have been several recent but conflicting reports of measurements of INaCaX in cells isolated from animal models of hypertrophy and CHF. One recent report found a decrease in INaCaX in a similar model of MI in rat heart (47). The cells were studied 3 wk after the MI, selection of animals was not made on the basis of LVEDP, the cellular hypertrophy was significantly less than in the present study, and the cells were studied at a lower temperature. Thus the data are not directly comparable to the present study. Litwin and Bridge (28) found that INaCaX was increased in a model of MI in rabbit heart. In addition, O'Rourke and co-workers (33, 46) found that a 28% reduction in sarco(endo)plasmic reticulum Ca2+-ATPase subunit 2a (SERCA2a) and phospholamban in the pacing-induced model of heart failure in dog was accompanied by an increase in Na+/Ca2+ exchange protein of 100%. Schwinger et al. (37) recently reported no change in exchanger protein levels, despite evidence of an increase in activity in failing human heart (35).
We found a near doubling in INaCaX in the rat model of MI under our experimental conditions. This was accompanied by a modest (30-40%) upregulation of exchanger mRNA and protein levels. We carefully selected viable tissue from the left ventricle for analysis, which was important since there was a strong upregulation of the Na+/Ca2+ exchanger signal in the scar tissue. Thus it appears that species differences or differences in experimental model of CHF cause a similar final outcome via different mechanisms. In the rat MI model, our observations suggest that the exchange rate is increased, although the mechanism for this increase is not clear from the present results but may involve altered regulation of the exchanger in addition to a small increase in protein expression. In either model, however, it is not at all surprising that the failing heart might increase the capacity for Ca2+ removal from the cytoplasm via the exchanger in response to a diminished SR uptake rate (33, 46). Thus the increase in Na+/Ca2+ exchange, however it is achieved, may ultimately prove to be a compensatory mechanism to overcome a defect in cytoplasmic Ca2+ removal. Such a compensatory response of increasing Na+/Ca2+ exchange rate might also explain the observation that MI cells have a reduced sensitivity to ICa blockade. Because the characteristics of ICa are unchanged, as is its ability to trigger contraction in the absence of a contribution of the exchanger (0 mM Na+ conditions), there may simply be a greater contribution of the exchanger to serve as a more effective trigger in MI than in Sham cells. An increased role of the Na+/Ca2+ exchanger, particularly in relaxation, was also recently reported on the basis of experiments on cardiomyocytes from human failing hearts (12, 13). Estimated equilibrium potential for Na+/Ca2+ exchange is
10 mV under these
experimental conditions (with the assumption of an internal
Ca2+ concentration of 100 nM). Finally, the fact that all
remaining verapamil-insensitive contraction was blocked by
Ni2+ supports this idea, since Ni2+ is an
effective blocker of the exchanger in this concentration range
(20, 45).
In conclusion, the present results demonstrate the following:
1) Two mechanisms appear to participate in the activation of contraction in Sham and MI cells. Both cause an influx of
Ca2+ that is capable of triggering Ca2+-induced
release of Ca2+ from stores in the SR and resulting in
contraction. 2) One mechanism is the influx of
Ca2+ by voltage-gated, L-type Ca2+ channels,
which is blocked by organic and inorganic (divalent cation)
antagonists. 3) A second mechanism also appears to be involved in triggering E-C coupling in Sham and MI cells that may
involve reverse-mode Na+/Ca2+ exchange, which
is activated by depolarization and blocked by Ni2+.
4) The relative contributions of the two mechanisms to E-C
coupling are altered in hypertrophied cells surviving MI where
INaCaX is nearly doubled, thus increasing the
potential efficacy of this mechanism to trigger contraction.
5) The doubling of INaCaX was much
greater than the increase of exchanger protein content, suggesting changes in the regulation of exchange kinetics in MI.
The involvement of these mechanisms in the triggering of contraction in
normal and diseased myocardium remains to be clarified, as does their
relative contribution to normal and abnormal E-C coupling. One
intriguing suggestion is that the two mechanisms may sum in a nonlinear
fashion because of the sigmoidal relationship between the open
probability of the SR Ca2+ release channel and changes in
internal Ca2+, such that the two triggers may act
synergistically in the modulation of SR release (29). It
must also be considered that there may be pronounced differences in
phenotypes between rat and human models of MI and heart failure. Even
so, this study points to the considerable clinical importance of
determining whether the increased activity of the exchanger and the
concomitant increased role in E-C coupling in MI cells is the result of
MI, hypertrophy, or CHF or some critical combination of these
clinically relevant conditions. In addition to its contribution to E-C
coupling, the potential for an increased INaCaX
contribution to inward current and, therefore, to arrhythmogenesis
after MI indicates another important consequence of the upregulation in
exchanger activity found in this disease model.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Bjørn Amundsen, Morten Eriksen, Unni Lie Henriksen, Bjørn Kristiansen, Severin Leraand, Thea S. Solum, and Gerd Torgersen for expert technical assistance.
| |
FOOTNOTES |
|---|
This study was supported by the Research Council of Norway, Anders Jahre's Fund for Promotion of Science, the Laerdal Foundation, Rakel and Otto C. Bruun's Fund, and National Heart, Lung, and Blood Institute Grant HL-30724 (to J. A. Wasserstrom).
Address for reprint requests and other correspondence: J. A. Wasserstrom, Div. of Cardiology
S203, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611 (E-mail: ja-wasserstrom{at}northwestern.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 7 June 1999; accepted in final form 2 February 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Anand, IS,
Liu D,
Chugh SS,
Prahash AJ,
Gupta S,
John R,
Popescu F,
and
Chandrashekhar Y.
Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction.
Circulation
96:
3974-3984,
1997
2.
Barcenas-Ruiz, L,
and
Wier WG.
Voltage dependence of intracellular [Ca2+]i transients in guinea pig ventricular myocytes.
Circ Res
61:
148-154,
1987
3.
Benitah, JP,
Gomez AM,
Delgado C,
Lorente P,
and
Lederer WJ.
A chloride current component induced by hypertrophy in rat ventricular myocytes.
Am J Physiol Heart Circ Physiol
272:
H2500-H2506,
1997
4.
Berlin, JR,
Cannel MB,
and
Lederer WJ.
Regulation of twitch tension in sheep cardiac Purkinje fibers during calcium overload.
Am J Physiol Heart Circ Physiol
253:
H1540-H1547,
1987
5.
Beuckelmann, DJ,
and
Erdmann E.
Ca2+ currents and intracellular [Ca2+]i transients in single ventricular myocytes isolated from terminally failing human myocardium.
Basic Res Cardiol
87 Suppl1:
235-243,
1992.
6.
Beuckelmann, DJ,
Näbauer M,
and
Erdmann E.
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.
Circulation
85:
1046-1055,
1992
7.
Beuckelmann, DJ,
Näbauer M,
and
Erdmann E.
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure.
Circ Res
73:
379-385,
1993
8.
Boerth, SR,
and
Artman M.
Thyroid hormone regulates Na+-Ca2+ exchanger expression during postnatal maturation and in adult rabbit ventricular myocardium.
Cardiovasc Res
31:
E145-E152,
1996.
9.
Boerth, SR,
Zimmer DB,
and
Artman M.
Steady-state mRNA levels of the sarcolemmal Na+-Ca2+ exchanger peak near birth in developing rabbit and rat hearts.
Circ Res
74:
354-359,
1994
10.
Clemo, HF,
Stambler BS,
and
Baumgarten CM.
Persistent activation of a swelling-activated cation current in ventricular myocytes from dogs with tachycardia-induced congestive heart failure.
Circ Res
83:
147-157,
1998
11.
Dhalla, N,
Wang X,
and
Beamish RE.
Intracellular calcium handling in normal and failing hearts.
Exp Clin Cardiol
1:
7-20,
1996.
12.
Dipla, K,
Mattiello JA,
Margulies KB,
Jeevanandam V,
and
Houser SR.
The sarcoplasmic reticulum and the Na+/Ca2+ exchanger both contribute to the Ca2+ transient of failing human ventricular myocytes.
Circ Res
84:
435-444,
1999
13.
Gaughan, JP,
Furukawa S,
Jeevanandam V,
Hefner CA,
Kubo H,
Margulies KB,
McGowan BS,
Mattiello JA,
Dipla K,
Piacentino V, III,
Li S,
and
Houser SR.
Sodium/calcium exchange contributes to contraction and relaxation in failed human ventricular myocytes.
Am J Physiol Heart Circ Physiol
277:
H714-H724,
1999
14.
Gomez, AM,
Valdivia HH,
Cheng H,
Lederer MR,
Santana LF,
Cannell MB,
McCune SA,
Altschuld RA,
and
Lederer WJ.
Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.
Science
276:
800-806,
1997
15.
Gwathmey, JK,
Copelas L,
MacKinnon R,
Schoen FJ,
Feldman MD,
Grossman W,
and
Morgan JP.
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.
Circ Res
61:
70-76,
1987
16.
Han, X,
Ploug T,
and
Galbo H.
Effect of diet on insulin- and contraction-mediated glucose transport and uptake in rat muscle.
Am J Physiol Regulatory Integrative Comp Physiol
269:
R544-R551,
1995
17.
Hatem, SN,
Sham JS,
and
Morad M.
Enhanced Na+-Ca2+ exchange activity in cardiomyopathic Syrian hamster.
Circ Res
74:
253-261,
1994
18.
Holt, E,
and
Christensen G.
Transient Ca2+ overload alters Ca2+ handling in rat cardiomyocytes: effects on shortening and relaxation.
Am J Physiol Heart Circ Physiol
273:
H573-H582,
1997
19.
Jahnel, U,
Klemm P,
and
Nawrath H.
Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes.
Naunyn Schmiedebergs Arch Pharmacol
349:
87-94,
1994[Web of Science][Medline].
20.
Kimura, J,
Miyamae S,
and
Noma A.
Identification of sodium-calcium exchange current in single ventricular cells of guinea-pig.
J Physiol (Lond)
384:
199-222,
1987
21.
Kohmoto, O,
Levi AJ,
and
Bridge JH.
Relation between reverse sodium-calcium exchange and sarcoplasmic reticulum calcium release in guinea pig ventricular cells.
Circ Res
74:
550-554,
1994
22.
Laemmli, UK.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1970[Medline].
23.
Leblanc, N,
and
Hume JR.
Sodium current-induced release of calcium from cardiac sarcoplasmic reticulum.
Science
248:
372-376,
1990
24.
Levi, AJ,
Li J,
Spitzer KW,
and
Bridge JH.
Effect on the indo-1 transient of applying Ca2+ channel blocker for a single beat in voltage-clamped guinea-pig cardiac myocytes.
J Physiol (Lond)
494:
653-673,
1996
25.
Levi, AJ,
Mitcheson JS,
and
Hancox JC.
The effect of internal sodium and caesium on phasic contraction of patch-clamped rabbit ventricular myocytes.
J Physiol (Lond)
492:
1-19,
1996
26.
Levi, AJ,
Spitzer KW,
Kohmoto O,
and
Bridge JH.
Depolarization-induced Ca entry via Na-Ca exchange triggers SR release in guinea pig cardiac myocytes.
Am J Physiol Heart Circ Physiol
266:
H1422-H1433,
1994
27.
Lipp, P,
and
Niggli E.
Sodium current-induced calcium signals in isolated guinea-pig ventricular myocytes.
J Physiol (Lond)
474:
439-446,
1994
28.
Litwin, SE,
and
Bridge JH.
Enhanced Na+-Ca2+ exchange in the infarcted heart. Implications for excitation-contraction coupling.
Circ Res
81:
1083-1093,
1997
29.
Litwin, SE,
Li J,
and
Bridge JHB
Na-Ca exchange and the trigger for sarcoplasmic reticulum Ca release: studies in adult rabbit ventricular myocytes.
Biophys J
75:
359-371,
1998[Web of Science][Medline].
30.
McCullagh, KJ,
Poole RC,
Halestrap AP,
O'Brien M,
and
Bonen A.
Role of the lactate transporter (MCT1) in skeletal muscles.
Am J Physiol Endocrinol Metab
271:
E143-E150,
1996
31.
Mewes, T,
and
Ravens U.
L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium.
J Mol Cell Cardiol
26:
1307-1320,
1994[Web of Science][Medline].
32.
Nuss, HB,
and
Houser SR.
Sodium-calcium exchange-mediated contractions in feline ventricular myocytes.
Am J Physiol Heart Circ Physiol
263:
H1161-H1169,
1992
33.
O'Rourke, B,
Kass DA,
Tomaselli GF,
Kaab S,
Tunin R,
and
Marban E.
Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I. Experimental studies.
Circ Res
84:
562-570,
1999
34.
Pieske, B,
Sutterlin M,
Schmidt-Schweda S,
Minami K,
Meyer M,
Olschewski M,
Holubarsch C,
Just H,
and
Hasenfuss G.
Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling.
J Clin Invest
98:
764-776,
1996[Web of Science][Medline].
35.
Reinecke, H,
Studer R,
Vetter R,
Holtz J,
and
Drexler H.
Cardiac Na+/Ca2+ exchange activity in patients with end-stage heart failure.
Cardiovasc Res
31:
48-54,
1996[Web of Science][Medline].
36.
Rozanski, GJ,
Xu Z,
Zhang K,
and
Patel KP.
Altered K+ current of ventricular myocytes in rats with chronic myocardial infarction.
Am J Physiol Heart Circ Physiol
274:
H259-H265,
1998
37.
Schwinger, RH,
Wang J,
Frank K,
Muller-Ehmsen J,
Brixius K,
McDonough AA,
and
Erdmann E.
Reduced sodium pump
1-,
3-, and
1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure.
Circulation
99:
2105-2112,
1999
38.
Semb, SO,
Lunde PK,
Holt E,
Tønnessen T,
Christensen G,
and
Sejersted OM.
Reduced myocardial Na+,K+-pump capacity in congestive heart failure following myocardial infarction in rats.
J Mol Cell Cardiol
30:
1311-1328,
1998[Web of Science][Medline].
39.
Sipido, KR,
Maes M,
and
Van de Werf F.
Low efficiency of Ca2+ entry through the Na+-Ca2+ exchanger as trigger for Ca2+ release from the sarcoplasmic reticulum. A comparison between L-type Ca2+ current and reverse-mode Na+-Ca2+ exchange.
Circ Res
81:
1034-1044,
1997
40.
Studer, R,
Reinecke H,
Bilger J,
Eschenhagen T,
Bohm M,
Hasenfuss G,
Just H,
Holtz J,
and
Drexler H.
Gene expression of the cardiac Na+-Ca2+ exchanger in end-stage human heart failure.
Circ Res
75:
443-453,
1994
41.
Tønnessen, T,
Christensen G,
Øie E,
Holt E,
Kjekshus H,
Smiseth OA,
Sejersted OM,
and
Attramadal H.
Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats.
Cardiovasc Res
33:
601-610,
1997[Web of Science][Medline].
42.
Wasserstrom, JA,
and
Vites AM.
The role of Na+-Ca2+ exchange in activation of excitation-contraction coupling in rat ventricular myocytes.
J Physiol (Lond)
493:
529-542,
1996
43.
Wasserstrom, JA,
and
Vites AM.
Activation of contraction in cat ventricular myocytes: effects of low Cd2+ concentration and temperature.
Am J Physiol Heart Circ Physiol
277:
H488-H498,
1999
44.
Wier, WG.
Cytoplasmic [Ca2+] in mammalian ventricle: dynamic control by cellular processes.
Annu Rev Physiol
52:
467-485,
1990[Web of Science][Medline].
45.
Wier, WG,
and
Beuckelmann DJ.
Sodium-calcium exchange in mammalian heart: current-voltage relation and intracellular calcium concentration.
Mol Cell Biochem
89:
97-102,
1989[Web of Science][Medline].
46.
Winslow, RL,
Rice J,
Jafri S,
Marban E,
and
O'Rourke B.
Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. II. Model studies.
Circ Res
84:
571-586,
1999
47.
Zhang, X-Q,
Tillotson DL,
Moore RL,
Zelis R,
and
Cheung JY.
Na+/Ca2+ exchange currents and SR Ca2+ contents in postinfarction myocytes.
Am J Physiol Cell Physiol
271:
C1800-C1807,
1996
This article has been cited by other articles:
![]() |
J. A. Wasserstrom, R. Sharma, S. Kapur, J. E. Kelly, A. H. Kadish, C. W. Balke, and G. L. Aistrup Multiple Defects in Intracellular Calcium Cycling in Whole Failing Rat Heart Circ Heart Fail, May 1, 2009; 2(3): 223 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Swift, J. A. K. Birkeland, N. Tovsrud, U. H. Enger, J. M. Aronsen, W. E. Louch, I. Sjaastad, and O. M. Sejersted Altered Na+/Ca2+-exchanger activity due to downregulation of Na+/K+-ATPase {alpha}2-isoform in heart failure Cardiovasc Res, April 1, 2008; 78(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Wasserstrom and G. L. Aistrup Digitalis: new actions for an old drug Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1781 - H1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, X.-Q. Zhang, J. Wang, L. L. Carl, B. A. Ahlers, L. I. Rothblum, and J. Y. Cheung Sprint training improves contractility in postinfarction rat myocytes: role of Na+/Ca2+ exchange J Appl Physiol, August 1, 2004; 97(2): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sah, R. J Ramirez, G. Y Oudit, D. Gidrewicz, M. G Trivieri, C. Zobel, and P. H Backx Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (Ito) J. Physiol., January 1, 2003; 546(1): 5 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sjaastad, J. Bokenes, F. Swift, J. A. Wasserstrom, and O. M. Sejersted Normal contractions triggered by ICa,L in ventricular myocytes from rats with postinfarction CHF Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1225 - H1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B Sande, I. Sjaastad, I. B Hoen, J. Bokenes, T. Tonnessen, E. Holt, P. K Lunde, and G. Christensen Reduced level of serine16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity Cardiovasc Res, February 1, 2002; 53(2): 382 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Johannsson, P. K. Lunde, C. Heddle, I. Sjaastad, M. J. Thomas, L. Bergersen, A. P. Halestrap, T. W. Blackstad, O. P. Ottersen, and O. M. Sejersted Upregulation of the Cardiac Monocarboxylate Transporter MCT1 in a Rat Model of Congestive Heart Failure Circulation, August 7, 2001; 104(6): 729 - 734. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |